NCT01266369View on ClinicalTrials.gov

Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation

PHASE2CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

May 31, 2010

Conditions

Mastocytosis

Interventions

DRUG

masitinib

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AB Science

INDUSTRY